Inflammatory Markers in Exhaled Breath Condensates From Asthmatic Patients

Asthma Clinical Trial

Official title:

Inflammatory Markers in Exhaled Breath Condensates From Asthmatic Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01246414
• Other study ID #: Chula-ARC 001/10
• Status: Completed
• Phase: N/A
• First received: January 4, 2010
• Last updated: November 22, 2010
• Start date: January 2010
• Est. completion date: May 2010

Study information

• Verified date: November 2010
• Source: Chulalongkorn University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Thailand: Ethical Committee
• Study type: Observational

Clinical Trial Summary

This study aims to compare the inflammatory mediators in exhaled breathe condensates from allergic and non-allergic asthmatic patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 38
• Est. completion date: May 2010
• Est. primary completion date: April 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 15 Years to 65 Years

Eligibility

Inclusion Criteria:

1. Have been diagnosed as asthma at least 6 months before enrolled to the study

2. Known skin prick test results to aeroallergens ; either positive or negative

3. 15-65 years of age

Exclusion Criteria:

1. On oral or inhaled corticosteroids within 1 month before the study

2. Having asthma exacerbation

3. Being pregnant

4. Suffering from severe systemic disease/ in bad health

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Asthma

Locations

Country	Name	City	State
Thailand	Chulalongkorn University	Bangkok

Sponsors (2)

Lead Sponsor	Collaborator
Chulalongkorn University	Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Levels of inflammatory cytokines in exhaled breathe condensates		4 months	No